- Home
- EVGN vs AWH Comparison
EVGN vs AWH Comparison
Compare EVGN & AWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVGN
- AWH
- Stock Information
- Founded
- EVGN 1999
- AWH 1993
- Country
- EVGN Israel
- AWH United States
- Employees
- EVGN N/A
- AWH N/A
- Industry
- EVGN Agricultural Chemicals
- AWH Medical/Dental Instruments
- Sector
- EVGN Industrials
- AWH Health Care
- Exchange
- EVGN Nasdaq
- AWH Nasdaq
- Market Cap
- EVGN 9.7M
- AWH 12.8M
- IPO Year
- EVGN N/A
- AWH N/A
- Fundamental
- Price
- EVGN $1.35
- AWH $0.77
- Analyst Decision
- EVGN Strong Buy
- AWH Buy
- Analyst Count
- EVGN 1
- AWH 2
- Target Price
- EVGN $12.00
- AWH $4.40
- AVG Volume (30 Days)
- EVGN 58.6K
- AWH 81.4K
- Earning Date
- EVGN 11-21-2024
- AWH 11-14-2024
- Dividend Yield
- EVGN N/A
- AWH N/A
- EPS Growth
- EVGN N/A
- AWH N/A
- EPS
- EVGN N/A
- AWH N/A
- Revenue
- EVGN $7,478,000.00
- AWH $8,963,000.00
- Revenue This Year
- EVGN $90.35
- AWH $11.87
- Revenue Next Year
- EVGN $38.71
- AWH $79.10
- P/E Ratio
- EVGN N/A
- AWH N/A
- Revenue Growth
- EVGN 30.69
- AWH N/A
- 52 Week Low
- EVGN $1.20
- AWH $0.67
- 52 Week High
- EVGN $10.40
- AWH $5.65
- Technical
- Relative Strength Index (RSI)
- EVGN 36.47
- AWH 48.00
- Support Level
- EVGN $1.20
- AWH $0.68
- Resistance Level
- EVGN $1.49
- AWH $0.85
- Average True Range (ATR)
- EVGN 0.12
- AWH 0.08
- MACD
- EVGN 0.01
- AWH 0.00
- Stochastic Oscillator
- EVGN 35.71
- AWH 42.86
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment followed by Industry.
About AWH Aspira Women's Health Inc.
Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.